EiPLA
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is an isomer of ETH-LAD.
EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is an isomer of ETH-LAD.
Use and effects
EiPLA has been identified in blotter containing doses of 86 to 97 μg base equivalent per tab. Blotter containing 200 μg per tab has also been described. Anecdotal reports suggest that EiPLA produces psychedelic effects but is less potent than LSD.
Interactions
Pharmacology
Pharmacodynamics
In drug discrimination tests in rodents, EiPLA was found to have approximately half the potency of LSD.
Chemistry
Analogues
Analogues of EiPLA include MiPLA, LAMPA (MPLA), EPLA, EcPLA, and ETFELA, among others.
History
EiPLA was first described in the scientific literature by David E. Nichols and colleagues by at least 1994. It appears to have emerged as a novel designer drug by 2019.
See also
Substituted lysergamide Lizard Labs
References
External links
EiPLA - Isomer Design The Big & Dandy EiPLA Thread - Bluelight
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374834742 under CC BY-SA 4.0; modifications have been made.